Haemonetics Announces 1,623-Patient Study Of VASCADE MVP XL Closure System Showing 92.5% Same-Day Discharge Rate And 1.2% Overall Vascular Complications

Loading news article.

Haemonetics Announces 1,623-Patient Study Of VASCADE MVP XL Closure System Showing 92.5% Same-Day Discharge Rate And 1.2% Overall Vascular Complications | WAPE

Haemonetics Announces 1,623-Patient Study Of VASCADE MVP XL Closure System Showing 92.5% Same-Day Discharge Rate And 1.2% Overall Vascular Complications

Article summary

Related companies

Comments —